These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 29570807)
21. Chitinase-3-Like Protein 1, Serum Amyloid A1, C-Reactive Protein, and Procalcitonin Are Promising Biomarkers for Intracranial Severity Assessment of Traumatic Brain Injury: Relationship with Glasgow Coma Scale and Computed Tomography Volumetry. Carabias CS; Gomez PA; Panero I; Eiriz C; Castaño-León AM; Egea J; Lagares A; World Neurosurg; 2020 Feb; 134():e120-e143. PubMed ID: 31606503 [TBL] [Abstract][Full Text] [Related]
22. Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury. Mondello S; Kobeissy F; Vestri A; Hayes RL; Kochanek PM; Berger RP Sci Rep; 2016 Jun; 6():28203. PubMed ID: 27319802 [TBL] [Abstract][Full Text] [Related]
23. Simplifying the use of prognostic information in traumatic brain injury. Part 2: Graphical presentation of probabilities. Murray GD; Brennan PM; Teasdale GM J Neurosurg; 2018 Jun; 128(6):1621-1634. PubMed ID: 29631517 [TBL] [Abstract][Full Text] [Related]
25. The relationship between serum fibrinogen-like protein 2 concentrations and 30-day mortality of patients with traumatic brain injury. Chen TJ; Ji MX; Tao ZQ; Fu QY; Xiong K; Cheng B Clin Chim Acta; 2019 Feb; 489():53-57. PubMed ID: 30503273 [TBL] [Abstract][Full Text] [Related]
26. Effect of Memantine on Serum Levels of Neuron-Specific Enolase and on the Glasgow Coma Scale in Patients With Moderate Traumatic Brain Injury. Mokhtari M; Nayeb-Aghaei H; Kouchek M; Miri MM; Goharani R; Amoozandeh A; Akhavan Salamat S; Sistanizad M J Clin Pharmacol; 2018 Jan; 58(1):42-47. PubMed ID: 28724200 [TBL] [Abstract][Full Text] [Related]
27. Moderate and severe traumatic brain injury: effect of blood alcohol concentration on Glasgow Coma Scale score and relation to computed tomography findings. Rundhaug NP; Moen KG; Skandsen T; Schirmer-Mikalsen K; Lund SB; Hara S; Vik A J Neurosurg; 2015 Jan; 122(1):211-8. PubMed ID: 25361494 [TBL] [Abstract][Full Text] [Related]
28. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial. Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854 [TBL] [Abstract][Full Text] [Related]
29. The 90-day prognostic value of serum cyclophilin A in traumatic brain injury. Jin HH; Mao TM; Bai ZQ; Chen Y; Ji HL; Jin Y Clin Chim Acta; 2018 Sep; 484():258-264. PubMed ID: 29885319 [TBL] [Abstract][Full Text] [Related]
30. Estradiol to Androstenedione Ratios Moderate the Relationship between Neurological Injury Severity and Mortality Risk after Severe Traumatic Brain Injury. Ranganathan P; Kumar RG; Oh BM; Rakholia MV; Berga SL; Wagner AK J Neurotrauma; 2019 Feb; 36(4):538-547. PubMed ID: 30014751 [TBL] [Abstract][Full Text] [Related]
31. Serum macrophage migration inhibitory factor concentrations correlate with prognosis of traumatic brain injury. Yang DB; Yu WH; Dong XQ; Zhang ZY; Du Q; Zhu Q; Che ZH; Wang H; Shen YF; Jiang L Clin Chim Acta; 2017 Jun; 469():99-104. PubMed ID: 28366792 [TBL] [Abstract][Full Text] [Related]
32. The diagnostic values of UCH-L1 in traumatic brain injury: A meta-analysis. Shahjouei S; Sadeghi-Naini M; Yang Z; Kobeissy F; Rathore D; Shokraneh F; Blackburn S; Manley GT; Wang KKW Brain Inj; 2018; 32(1):1-17. PubMed ID: 29087740 [TBL] [Abstract][Full Text] [Related]
33. Prognosis of Severe Traumatic Brain Injury Outcomes in Children. Meshcheryakov SV; Semenova ZB; Lukianov VI; Sorokina EG; Karaseva OV Acta Neurochir Suppl; 2018; 126():11-16. PubMed ID: 29492523 [TBL] [Abstract][Full Text] [Related]
34. Associations of Microvascular Injury-Related Biomarkers With Traumatic Brain Injury Severity and Outcomes: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Pilot Study. Schneider ALC; Huie JR; Jain S; Sun X; Ferguson AR; Lynch C; Yue JK; Manley GT; Wang KKW; Sandsmark DK; Campbell C; Diaz-Arrastia R J Neurotrauma; 2023 Aug; 40(15-16):1625-1637. PubMed ID: 37021339 [TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of serum translocator protein in patients with traumatic brain injury. Luo LF; Weng JF; Cen M; Dong XQ; Yu WH; Du Q; Yang DB; Zheng YK; Hu W; Yu L; Luo SD Clin Chim Acta; 2019 Jan; 488():25-30. PubMed ID: 30385279 [TBL] [Abstract][Full Text] [Related]
36. Plasma Levels, Temporal Trends and Clinical Associations between Biomarkers of Inflammation and Vascular Homeostasis after Pediatric Traumatic Brain Injury. Lele AV; Alunpipatthanachai B; Qiu Q; Clark-Bell C; Watanitanon A; Moore A; Chesnut RM; Armstead W; Vavilala MS Dev Neurosci; 2019; 41(3-4):177-192. PubMed ID: 31553988 [TBL] [Abstract][Full Text] [Related]
37. Traumatic brain injury: It is all about definition. Savitsky B; Givon A; Rozenfeld M; Radomislensky I; Peleg K Brain Inj; 2016; 30(10):1194-200. PubMed ID: 27466967 [TBL] [Abstract][Full Text] [Related]
38. Early CSF and Serum S100B Concentrations for Outcome Prediction in Traumatic Brain Injury and Subarachnoid Hemorrhage. Kellermann I; Kleindienst A; Hore N; Buchfelder M; Brandner S Clin Neurol Neurosurg; 2016 Jun; 145():79-83. PubMed ID: 27101088 [TBL] [Abstract][Full Text] [Related]
39. Copeptin's role in traumatic brain injury: The promising quest for a new biomarker. Săcărescu A; Pleşca IC; Turliuc MD Clin Neurol Neurosurg; 2024 Sep; 244():108432. PubMed ID: 38986366 [TBL] [Abstract][Full Text] [Related]